These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28057561)

  • 21. Herpesviruses and immunity: the art of evasion.
    Griffin BD; Verweij MC; Wiertz EJ
    Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?
    Sehrawat S; Kumar D; Rouse BT
    Front Cell Infect Microbiol; 2018; 8():177. PubMed ID: 29888215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple sclerosis and herpetic infection].
    Kruhliak HO
    Lik Sprava; 2004; (1):3-8. PubMed ID: 17051701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Are non-bovine Artiodactyla IBR virus reservoirs? I. BHV-1 and CapHV-1 infection and reactivation studies to show virus type specificity of humoral antibodies and characterization of viral antigens].
    Ackermann M; Metzler AE; McDonagh H; Bruckner L; Müller HK; Kihm U
    Schweiz Arch Tierheilkd; 1986 Nov; 128(11):557-73. PubMed ID: 3026040
    [No Abstract]   [Full Text] [Related]  

  • 25. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpesvirus exploitation of host immune inhibitory pathways.
    Stack G; Stacey MA; Humphreys IR
    Viruses; 2012 Aug; 4(8):1182-201. PubMed ID: 23012619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolution of the Humoral Response during HCV Infection: Theories on the Origin of Broadly Neutralizing Antibodies and Implications for Vaccine Design.
    Murira A; Lapierre P; Lamarre A
    Adv Immunol; 2016; 129():55-107. PubMed ID: 26791858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of glycoprotein gp1 of bovine herpesvirus type 4.
    Dubuisson J; Pastoret PP; Thiry E
    J Gen Virol; 1992 May; 73 ( Pt 5)():1293-6. PubMed ID: 1316948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL; Sharma JM; Offenbecker L
    Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding human T-cell-mediated immunoregulation through herpesviruses.
    Burrows SR; Moss DJ; Khanna R
    Immunol Cell Biol; 2011 Mar; 89(3):352-8. PubMed ID: 21301481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression analysis of common carp (Cyprinus carpio L.) lines during Cyprinid herpesvirus 3 infection yields insights into differential immune responses.
    Rakus KŁ; Irnazarow I; Adamek M; Palmeira L; Kawana Y; Hirono I; Kondo H; Matras M; Steinhagen D; Flasz B; Brogden G; Vanderplasschen A; Aoki T
    Dev Comp Immunol; 2012 May; 37(1):65-76. PubMed ID: 22212509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-herpesvirus agents: a patent and literature review (2003 to present).
    Skoreński M; Sieńczyk M
    Expert Opin Ther Pat; 2014 Aug; 24(8):925-41. PubMed ID: 25010889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-regulation between herpesviruses and the TNF superfamily members.
    Sedý JR; Spear PG; Ware CF
    Nat Rev Immunol; 2008 Nov; 8(11):861-73. PubMed ID: 18949019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Herpesvirus infections in animals].
    Mayr A
    Hautarzt; 1986 May; 37(5):255-8. PubMed ID: 3015841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the replication of herpes viruses by phosphonoacetate and related compounds.
    Newton AA
    Adv Ophthalmol; 1979; 38():267-75. PubMed ID: 230719
    [No Abstract]   [Full Text] [Related]  

  • 37. Herpesviruses and the microbiome.
    Dreyfus DH
    J Allergy Clin Immunol; 2013 Dec; 132(6):1278-86. PubMed ID: 23611298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments with herpesviruses and the nervous system.
    Picard FJ; Poland SD; Rice GP
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):169-75. PubMed ID: 8386954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
    Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
    Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Training of the immune system of foals against ERP virus infections by frequent vaccination with presently available commercial vaccines].
    Bürki F; Nowotny N; Rossmanith W; Pallan C; Möstl K
    Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):162-5. PubMed ID: 2540944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.